Free Trial

Sonova (OTCMKTS:SONVY) Sets New 1-Year High - Still a Buy?

Sonova logo with Medical background

Shares of Sonova Holding AG (OTCMKTS:SONVY - Get Free Report) reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $75.04 and last traded at $74.67, with a volume of 11562 shares changing hands. The stock had previously closed at $73.60.

Analyst Ratings Changes

Separately, UBS Group upgraded Sonova to a "hold" rating in a research note on Tuesday, August 13th.

View Our Latest Stock Report on SONVY

Sonova Stock Up 1.5 %

The business's 50-day moving average is $70.27 and its two-hundred day moving average is $63.78. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.07 and a current ratio of 1.45.

About Sonova

(Get Free Report)

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Sonova right now?

Before you consider Sonova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.

While Sonova currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar
Top 3 Stocks Under $20 with Strong Buy Ratings and Growth Potential
ISRG Stock Surges: AI and Healthcare Innovation at the Core

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines